Editorial:
Mark Henderson, Editor
The grandiose expectations of the biotechnology revolution associated with the heady days of the tech boom have faded from memory, but the platform technologies associated with it are expected to continue contributing to Canada’s economy for the foreseeable future.
Canada Foundation for Innovation lays out plans to broaden scope of support
New strategic roadmap
The Canada Foundation for Innovation (CFI) intends to encourage greater research collaboration between academia and the private sector by broadening the range of activities it supports, according to a new strategic roadmap that spells out its intentions for the next five years.
TRRA study examines which college and university attributes best meet industry needs
Southern Ontario manufacturing focus
Proximity and communication are key to expanded interaction between business and the academic sector in southern Ontario, according to a new study commissioned by the Toronto Regional Research Alliance (TRRA).
Looking beyond Canada for innovation that works
Analysis
By Dr WE (Ted) Hewitt
In releasing their long-anticipated report this fall, the members of the Expert Panel for the Review of Federal Support to Business Research & Development have done this country a great service.
Opinion Leader:
Brian Wixted and Adam Holbrook
Dr Brian Wixted
Are charities and foundations the new arbiters of research funding policy?
By Brian Wixted and Adam Holbrook
With the recent Jenkins report and the attention business R&D gets in the media and in academia, you’d be forgiven for thinking that there are only two sources of R&D funding — government and business.
Report authors say Canada needs to act or risk falling behind competition
HPC and cyberinfrastructure
A report on the state of Canadian high performance computing (HPC) and cyberinfrastructure (CI) wants a small group of experts convened quickly to determine future needs or risk falling behind other nations that have made them a priority for developing their knowledge-based economies.
Study estimates value of Canadian biotechnology will reach 4% of GDP by 2030
Commissioned by Genome Canada
A major new report on the production and use of biotechnology in Canada estimates the sector will continue its rapid growth over the next 18 years to a value of $144 billion, accounting for 4% of Canada’s nominal GDP by 2030.